Mankind Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE634S01028
  • NSEID: MANKIND
  • BSEID: 543904
INR
2,203.55
-4.8 (-0.22%)
BSENSE

Dec 05

BSE+NSE Vol: 3.06 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
Share Capital
41.26
40.06
40.06
40.06
40.06
Share Warrants & Outstandings
Total Reserve
14,247.46
9,299.78
7,395.10
6,115.17
4,681.94
Shareholder's Funds
14,332.39
9,363.09
7,435.22
6,155.23
4,722.00
Minority Interest
235.79
212.70
188.07
161.08
0.00
Long-Term Borrowings
5,526.19
24.87
23.15
49.19
57.67
Secured Loans
5,088.86
24.87
23.15
48.94
57.42
Unsecured Loans
437.33
0.00
0.00
0.25
0.25
Deferred Tax Assets / Liabilities
1,704.62
8.68
47.54
16.33
-35.98
Other Long Term Liabilities
34.03
30.67
30.67
23.14
13.4
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
155.06
123.12
97.89
80.00
72.24
Total Non-Current Liabilities
7,419.90
187.34
199.24
168.68
107.33
Current Liabilities
Trade Payables
1,133.40
777.06
1,008.18
1,076.38
666.97
Other Current Liabilities
909.45
744.19
407.84
463.75
275.36
Short Term Borrowings
2,956.84
171.17
139.49
818.83
176.86
Short Term Provisions
663.87
427.31
307.63
264.50
234.22
Total Current Liabilities
5,663.56
2,119.73
1,863.14
2,623.47
1,353.40
Total Liabilities
27,651.64
11,882.86
9,685.67
9,108.45
6,323.62
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
Gross Block
20,723.51
5,775.71
5,104.51
4,172.90
2,102.27
Less: Accumulated Depreciation
1,886.28
1,354.82
973.59
657.49
497.69
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
Net Block
18,837.23
4,420.89
4,130.92
3,515.41
1,604.58
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
306.13
207.10
493.19
669.87
371.62
Intangible assets under development
519.54
74.70
56.95
31.60
0.33
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
Non Current Investments
351.14
315.13
276.32
240.43
211.30
Long Term Loans & Advances
293.08
163.97
187.54
150.93
145.25
Other Non Current Assets
189.00
13.79
98.51
26.03
29.53
Total Non-Current Assets
20,663.37
5,314.64
5,357.80
4,701.63
2,416.98
Current Assets Loans & Advances
Current Investments
1,690.84
2,258.11
1,075.47
874.46
1,306.17
Inventories
2,093.71
1,553.46
1,498.46
1,760.24
1,183.54
Sundry Debtors
1,538.34
848.28
576.42
388.17
330.61
Cash and Bank
554.50
708.10
453.20
405.94
700.74
Other Current Assets
100.12
106.80
68.15
173.72
109.78
Short Term Loans and Advances
1,010.76
1,093.47
656.16
804.29
275.79
Total Current Assets
6,988.27
6,568.22
4,327.87
4,406.82
3,906.64
Net Current Assets (Including Current Investments)
1,324.71
4,448.49
2,464.74
1,783.35
2,553.24
Total Current Assets Excluding Current Investments
5,297.43
4,310.11
3,252.40
3,532.36
2,600.46
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
Total Assets
27,651.64
11,882.86
9,685.67
9,108.45
6,323.62
Contingent Liabilities
1,046.73
119.23
58.26
60.49
28.70
Total Debt
8,483.03
196.04
162.64
868.03
234.53
Book Value per share (adjusted)
347.37
233.73
185.61
153.65
117.88
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is 4,227.19% vs 20.54% in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is 10.96% vs 0.00% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 313.64% vs 0.08% in Mar 2024

stock-summary

Investments

YoY Growth in year ended Mar 2025 is 11.43% vs 14.05% in Mar 2024

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 6.40% vs 51.77% in Mar 2024

Compare Balance Sheet Results of Mankind Pharma
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
41.26
100.60
-59.34
-58.99%
Share Warrants & Outstandings
Total Reserve
14,247.46
23,852.50
-9,605.04
-40.27%
Shareholder's Funds
14,332.39
23,953.10
-9,620.71
-40.16%
Minority Interest
235.79
2,405.30
-2,169.51
-90.20%
Long-Term Borrowings
5,526.19
0.00
5,526.19
0.00%
Secured Loans
5,088.86
0.00
5,088.86
0.00%
Unsecured Loans
437.33
0.00
437.33
0.00%
Deferred Tax Assets / Liabilities
1,704.62
-1,831.20
3,535.82
193.09%
Other Long Term Liabilities
34.03
905.20
-871.17
-96.24%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
155.06
383.90
-228.84
-59.61%
Total Non-Current Liabilities
7,419.90
-542.10
7,962.00
1,468.73%
Current Liabilities
Trade Payables
1,133.40
2,305.80
-1,172.40
-50.85%
Other Current Liabilities
909.45
3,114.90
-2,205.45
-70.80%
Short Term Borrowings
2,956.84
3,169.50
-212.66
-6.71%
Short Term Provisions
663.87
451.40
212.47
47.07%
Total Current Liabilities
5,663.56
9,041.60
-3,378.04
-37.36%
Total Liabilities
27,651.64
34,857.90
-7,206.26
-20.67%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
20,723.51
21,699.80
-976.29
-4.50%
Less: Accumulated Depreciation
1,886.28
8,566.10
-6,679.82
-77.98%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
18,837.23
13,133.70
5,703.53
43.43%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
306.13
1,317.90
-1,011.77
-76.77%
Intangible assets under development
519.54
1,374.00
-854.46
-62.19%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
351.14
1,556.70
-1,205.56
-77.44%
Long Term Loans & Advances
293.08
407.60
-114.52
-28.10%
Other Non Current Assets
189.00
21.90
167.10
763.01%
Total Non-Current Assets
20,663.37
17,811.80
2,851.57
16.01%
Current Assets Loans & Advances
Current Investments
1,690.84
4,851.10
-3,160.26
-65.15%
Inventories
2,093.71
3,944.00
-1,850.29
-46.91%
Sundry Debtors
1,538.34
4,024.70
-2,486.36
-61.78%
Cash and Bank
554.50
2,956.80
-2,402.30
-81.25%
Other Current Assets
100.12
611.20
-511.08
-83.62%
Short Term Loans and Advances
1,010.76
658.30
352.46
53.54%
Total Current Assets
6,988.27
17,046.10
-10,057.83
-59.00%
Net Current Assets (Including Current Investments)
1,324.71
8,004.50
-6,679.79
-83.45%
Total Current Assets Excluding Current Investments
5,297.43
12,195.00
-6,897.57
-56.56%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
27,651.64
34,857.90
-7,206.26
-20.67%
Contingent Liabilities
1,046.73
731.80
314.93
43.03%
Total Debt
8,483.03
0.00
8,483.03
0.00%
Book Value per share (adjusted)
347.37
238.10
109.27
45.89%
Annual - Borrowings
Borrowings 8,483.03 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 4,227.19% vs 20.54% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 34.03 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 10.96% vs 0.00% in Mar 2024

Annual - Fixed Assets
Fixed Assets 19,143.36 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 313.64% vs 0.08% in Mar 2024

Annual - Investments
Investments 351.14 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 11.43% vs 14.05% in Mar 2024

Annual - Current Assets
Current Assets 6,988.27 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 6.40% vs 51.77% in Mar 2024